Helix BioMedix, Inc.
HXBM
$7.18
-$0.01-0.14%
OTC PK
| 09/30/2012 | 06/30/2012 | 03/31/2012 | 12/31/2011 | 09/30/2011 | |
|---|---|---|---|---|---|
| Revenue | 469.10K | 470.50K | 680.40K | 445.90K | 394.70K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 469.10K | 470.50K | 680.40K | 445.90K | 394.70K |
| Cost of Revenue | 135.20K | 164.50K | 209.50K | 132.00K | 127.80K |
| Gross Profit | 333.80K | 306.10K | 470.90K | 313.90K | 266.90K |
| SG&A Expenses | 926.10K | 780.10K | 906.90K | 756.40K | 720.90K |
| Depreciation & Amortization | 22.90K | 22.10K | 23.10K | 26.60K | 27.80K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.22M | 1.05M | 1.23M | 990.90K | 985.80K |
| Operating Income | -748.20K | -584.00K | -546.20K | -545.00K | -591.10K |
| Income Before Tax | -785.20K | -668.30K | -581.80K | -548.40K | -605.60K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -785.20K | -668.30K | -581.80K | -548.40K | -605.60K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -785.20K | -668.30K | -581.80K | -548.40K | -605.60K |
| EBIT | -748.20K | -584.00K | -546.20K | -545.00K | -591.10K |
| EBITDA | -725.30K | -562.00K | -523.10K | -518.40K | -563.20K |
| EPS Basic | -4.74 | -4.03 | -3.51 | -3.31 | -3.65 |
| Normalized Basic EPS | -2.96 | -2.50 | -2.17 | -2.09 | -2.31 |
| EPS Diluted | -4.74 | -4.03 | -3.51 | -3.31 | -3.65 |
| Normalized Diluted EPS | -2.96 | -2.50 | -2.17 | -2.09 | -2.31 |
| Average Basic Shares Outstanding | 165.70K | 165.70K | 165.70K | 165.70K | 165.70K |
| Average Diluted Shares Outstanding | 165.70K | 165.70K | 165.70K | 165.70K | 165.70K |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |